Back
Arrowhead Pharmaceuticals Quote, Financials, Valuation and Earnings
Sponsored
ARWR
Sponsored
32,481% Growth? Meet Mode Mobile's "EarnPhone"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
20
ARWR
Arrowhead Pharmaceuticals
Last Price:
21.14
Seasonality Move:
6.36%
7 Day Trial
ALL ACCESS PASS
$
7
Hint at where the next big move in the market will be this month
Spot the next big move with this free book from a hedge fund managerArrowhead Pharmaceuticals Price Quote
$21.14
+0.36 (+1.73%)
(Updated: September 19, 2024 at 4:40 PM ET)
Arrowhead Pharmaceuticals Key Stats
Sell
20
Arrowhead Pharmaceuticals (ARWR)
is a Sell
Day range:
$19.79 - $21.36
52-week range:
$19.44 - $39.83
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
13.21
P/B ratio:
7.82%
Volume:
1.4M
Avg. volume:
1.1M
1-year change:
-26.13%
Market cap:
$2.6B
Revenue:
$240.7M
EPS:
$-4.66
How Much Does Arrowhead Pharmaceuticals Make?
Data Unavailable
Is Arrowhead Pharmaceuticals Growing As A Company?
Data Unavailable
Arrowhead Pharmaceuticals Stock Price Performance
-
Did Arrowhead Pharmaceuticals Stock Go Up Last Month?
Arrowhead Pharmaceuticals share price went down by -8.46% last month -
Did ARWR's Share Price Rise Over The Last Year?
ARWR share price fell by -26.13% over the past 1 year
What Is Arrowhead Pharmaceuticals 52-Week High & Low?
-
What Is Arrowhead Pharmaceuticals’s 52-Week High Share Price?
Arrowhead Pharmaceuticals has traded as high as $39.83 over the past 52 weeks -
What Is Arrowhead Pharmaceuticals’s 52-Week Low Share Price?
Arrowhead Pharmaceuticals has traded as low as $19.44 over the past 52 weeks
Arrowhead Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Arrowhead Pharmaceuticals?
-
How Much Debt Does Arrowhead Pharmaceuticals Have?
Total long term debt quarterly is $0 -
How Much Cash Does Arrowhead Pharmaceuticals Have?
Cash and short term investments quarterly total is $434.5M -
What Is Arrowhead Pharmaceuticals’s Book Value Per Share?
Book value per share is 2.66
Is Arrowhead Pharmaceuticals Cash Flow Positive?
-
What Is ARWR Cash Flow From Operations?
Cash flow from operations (TTM) is -$351.6M -
What Is Arrowhead Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $482.3M -
What Is Arrowhead Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$166.6M
Arrowhead Pharmaceuticals Return On Invested Capital
Data Unavailable
Arrowhead Pharmaceuticals Earnings Date & Stock Price
-
What Is Arrowhead Pharmaceuticals's Stock Price Today?
A single share of ARWR can be purchased today for 20.78 -
What Is Arrowhead Pharmaceuticals’s Stock Symbol?
Arrowhead Pharmaceuticals trades on the nasdaq under the ticker symbol: ARWR -
When Is Arrowhead Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Arrowhead Pharmaceuticals is scheduled on November 29, 2024 -
When Is ARWR's next ex-dividend date?
Arrowhead Pharmaceuticals's next ex-dividend date is September 19, 2024 -
How To Buy Arrowhead Pharmaceuticals Stock?
You can buy Arrowhead Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Arrowhead Pharmaceuticals Competitors
-
Who Are Arrowhead Pharmaceuticals's Competitors?
Below is a list of companies who compete with Arrowhead Pharmaceuticals or are related in some way:
Arrowhead Pharmaceuticals Dividend Yield
-
What Is ARWR Dividend Yield?
Arrowhead Pharmaceuticals’s dividend yield currently is 0% -
What Is Arrowhead Pharmaceuticals’s Payout Ratio?
Arrowhead Pharmaceuticals’s payout ratio is 0% -
When Did Arrowhead Pharmaceuticals Last Pay A Dividend?
The latest dividend pay date is September 19, 2024 -
What Is Arrowhead Pharmaceuticals’s Dividend Per Share?
Arrowhead Pharmaceuticals pays a dividend of $0.00 per share
Arrowhead Pharmaceuticals Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -134.53% |
Revenue: | 0% | -100% |
Analyst Recommendations
Buy Recommendations: | 7 |
---|---|
Hold Recommendations: | 5 |
Sell Recommendations: | 0 |
Price Target: | 47.29 |
Upside from Last Price: | 127.55% |